Betta Pharmaceuticals Revenue

In the year 2024, Betta Pharmaceuticals had annual revenue of 2.89B CNY with 17.74% growth. Betta Pharmaceuticals had revenue of 547.31M in the quarter ending December 31, 2024, with 32.63% growth.

Revenue

2.89B

Revenue Growth

+17.74%

P/S Ratio

6.97

Revenue / Employee

1.57M

Employees

1,961

Market Cap

21.43B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.89B	435.75M	17.74%
Dec 31, 2023	2.46B	79.57M	3.35%
Dec 31, 2022	2.38B	130.77M	5.82%
Jan 1, 2022	2.25B	375.59M	20.08%
Dec 31, 2020	1.87B	316.34M	20.36%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	37.11B
WuXi AppTec	37.92B
Zhangzhou Pientzehuang Pharmaceutical.,	10.77B
Aier Eye Hospital Group	20.98B
Sichuan Biokin Pharmaceutical	5.82B
Shanghai United Imaging Healthcare	10.30B
Yunnan Baiyao Group Co.,Ltd	40.03B

Revenue Rankings